Sawada, Masaaki
Ueda, Yutaka http://orcid.org/0000-0001-8760-6379
Yagi, Asami
Morimoto, Akiko
Nakae, Ruriko
Kakubari, Reisa
Abe, Hazuki
Egawa-Takata, Tomomi
Iwamiya, Tadashi
Matsuzaki, Shinya
Kobayashi, Eiji
Yoshino, Kiyoshi
Kimura, Tadashi
Funding for this research was provided by:
Japan Agency for Medical Research and Development (15ck0106103h0102)
Article History
Received: 8 May 2017
Accepted: 23 August 2017
First Online: 6 October 2017
Compliance with ethical standards
:
: This study was approved by our Institutional Review Board and Ethics Committee. Yutaka Ueda received a grant from the Japan Agency for Medical Research and Development (Grant Number 15ck0106103h0102) and has received lecture fees from GlaxoSmithKline/Japan Vaccine and received lecture fees, research funds, and consultation fees from Merck Sharp & Dohme. Asami Yagi received a lecture fee from Merck Sharp & Dohme. Tadashi Kimura received a lecture fee from GlaxoSmithKline/Japan Vaccine and research funds from Merck Sharp & Dohme.